Article In Press | Published on: October 10, 2026
Volume: 2, Issue: 1
1. Reproductive Endocrinology Laboratory, Department of Zoology, Gulbarga University Kalaburagi - 585106, Karnataka, India.
2. Pharmaceutical Chemistry Division, Department of Chemistry, Gulbarga University Kalaburagi - 585106 Karnataka, India.
Corresponding Author: Sharanabasappa A. Patil, Reproductive Endocrinology Laboratory, Department of Zoology, Gulbarga University Kalaburagi - 585106, Karnataka, India.
Citation: Sharanabasappa A. Patil, Somanath G. Patil. (2026). Ulcer Preventive Properties of Boerhaavia Diffusa on Acetyl Salicylic Acid/Pylorus Ligated Ulcer Model in Rats. Journal of Surgical Case Reports and Research, RPC Publishers, 2(2); DOI: 10.66609/JSCRR-rpc.26.00565.
Copyright: © 2026 Sharanabasappa A. Patil, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Ulcer protective activity of ethanol and water extract of Boerhaavia diffusa was studied in albino rats. The ethanol extract at two different doses of 400 and 800 mg/kg showed marked protection of the gastric mucosa on acetyl salicylic acid /pylorus ligated ulcer model. Whereas, the water extract was ineffective. Photochemical screening of ethanol and water extract has been carried out. The ulcer protective effect of ethanol extract may be due to increase in the gastric mucosa. Histological evidence supports the protection of gastric mucosa by the ethanol extract treatment.
1.
2. Kirtikar KR, Basu BD. (1935). Indian medicinal plants, III 2nd Ed.
3. Basu NR, Lal SB, Sharma SN. (1947). Investigations on Indian medicinal plants. Quart. J. Pharm. Pharmacol, 20:38.
4. Ojewole JAO, Adesin SK. (1985). Pharmacological potential of Boerhaavia diffusa (1985) Fitoterapia 56(1):31.
5. Gupta DR, Bhar A. (1984). Indian J. Chem. Sec. B, 23B(7):682.
6. Suri OP, Kant Ravi, Jaiswal RS, Suri KA, Atal CK. (1982). Boerhaavia diffusa, a new source of phytoecdysones. Planta Med, 44(3):180.
7. Harborne JB. (1973). Phytochemical methods, London; Chapman and Hall, 33:232.
8. Shhhay H, Kumarova SA, Fels SS, Meranz D, Mruenstein M, et al. (1945). Gastroentrology, 5:43.
9. Sharanabasappa A, Vijaykumar M, Saraswati BP. (2002). Effect of Momordica charantia seed extracts on ovarian and uterine activities in albino rats. Pharm. Biol, 40(7):501.
10. Kulkarni SK. (1999). Hand Book of Experimental Pharmacology, III ed., Vallabh Prakashan, Delhi, 172.
11. O Laughlin JC, Hoftiezer JW, Irey KJ, Scand J. (1981). Gastroentrology 67 (suppl): 211.
12. Lanza FL. (1987). Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am. J. Med, 77:19.
13. Laine L, Weinstein WM. (1988). Subepithelial hemorrhages and erosions of human stomach, Dig. Dis. Sci, 33:490.
14. Cameron AJ. (1975). Aspirin and gastric ulcer. Mayo. Clin. Proc, 50:565.
15. Levy M. (1974). Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease: a report from the Boston Collaborative Drug Surveillance Program, Boston. New England J. Med, 290:1158.
16. Armstrong CP, Blower AL. (1987). Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration. Gut, 28(5):527-532.
17. Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet, 1(8479):462-464.
18. Collier DS, Pain JA. (1985). Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut, 26(4):359-363.
19. Walt R, Logan R, Katchinski B, Ashley J, Langman M. (1986). Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet, 1:489-492.
20. Whittle BJ, Higgs GA, Eakins KE, Moncada S, Vane JR. (1980). Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature, 284:271-273.
21. Piper DW, Stiel DD. (1986). Pathogenesis of chronic peptic ulcer, current thinking and clinical implications[J]. Med Prog, 2:7-10.
22. Dhuley J.N. (1999). Protective effect of Rhinax a herbal formulation, Indian Journal of Pharmacology, (31):128-32.
23. Bilsky J, Sarosiek J, Murty V.L.N, Aono M, Moriga M. (1987). Enhancement of the lipid content and physical properties of gastric mucus by geranylgeranyl- acetone. Biochem. Pharmacol, 36:4059-4065.